Results 61 to 70 of about 1,717 (158)

Phenotype characterization of heart failure with preserved ejection fraction in medical device and surgical trials

ESC Heart Failure, Volume 12, Issue 6, Page 3878-3898, December 2025.
This systematic review identified 24 clinical trials of medical device and surgical interventions for HFpEF, with 16 demonstrating at least safety and feasibility, but little evidence of long‐term benefit. Phenotype‐based responses suggest that certain interventions may benefit specific HFpEF subgroups, yet most trials suffered from heterogeneous ...
Kurdo Araz, Francesco Fioretti, Sara Ladak, Mohammed Obaidan, Javed Butler, Aamir Hameed   +5 more
wiley   +1 more source

Paroxysmal sympathetic hyperactivity syndrome after recurrent stroke: A case report

Northwestern Medical Journal
Paroxysmal sympathetic hyperactivity (PSH) is a state of autonomic dysfunction characterized by symptoms such as tachypnea, tachycardia, hypertension, hyperthermia, sweating, and dystonia.
Fatma Bilgili, Serpil Yıldız, Şule Aydın Türkoğlu, Sadettin Ersoy   +3 more
doaj   +1 more source

A retrospective analysis of paroxysmal sympathetic hyperactivity following severe pediatric brain injury

Journal of Pediatric Rehabilitation Medicine, 2018
BACKGROUND: There are several gaps in the literature related to the prognosis and care of children who have experienced a brain injury then develop paroxysmal sympathetic hyperactivity (PSH).
Lisa Letzkus, Jessica Keim-Malpass, Joel Anderson, Mark Conaway, Peter Patrick, Christine Kennedy   +5 more
doaj   +1 more source

Managing the Complex Intersection Between Substance Use Disorders and Infectious Diseases

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 3, March 2026.
Karissa Chow, Amanda Binkley, Jessica Meisner, Samantha Huo, Matthew Hinton   +4 more
wiley   +1 more source

Marked Gingival Overgrowth Protruding from the Oral Cavity Due to Sodium Valproate

Diagnostics
Drug-induced gingival overgrowth is associated with various systemic diseases, including epilepsy. Among antiepileptic medications, phenytoin is commonly reported to cause this condition.
Mami Uegami, Hiroaki Ito, Tadashi Shiohama   +2 more
doaj   +1 more source

Neuropharmacology in pediatric traumatic brain injury

Journal of Pediatric Rehabilitation Medicine
Children with severe traumatic brain injury (TBI) experience medical complications including paroxysmal sympathetic hyperactivity, disorders of consciousness, mood disruption, agitation, and upper motor neuron syndrome.
Laura E. Black, Nancy Yeh, Emily Hillaker, Kavita Nadendla, Melissa Trovato   +4 more
doaj   +1 more source

Issue Information

Journal of Diabetes Investigation, Volume 17, Issue 7, Page 1083-1086, July 2026.
wiley   +1 more source

Contemporary Perspectives on Paroxysmal Sympathetic Hyperactivity Following Traumatic Brain Injury: A Critical Analysis of Current Evidence and Clinical Practice

Journal of Advanced Lung Health
Paroxysmal sympathetic hyperactivity (PSH) affects approximately 27% of severe traumatic brain injury survivors, yet remains challenging to diagnose and manage due to limited high-quality evidence. This critical perspective synthesizes recent advances in
Lt Col Sasidharan Shibu, Sunali Nanayakkara, Kirankumar Parate   +2 more
doaj   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Oral Presentation

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source